Gain a Competitive Edge: Own Your Gene Synthesis Workflow with In-House Oligo Synthesis Enabled by SYNTAX

In today’s competitive biotechnology landscape, control and speed define success for companies and core labs producing synthetic genes. Yet many gene synthesis teams still rely on outsourced oligo supply which introduces uncertainty, delays, and loss of control over workflows and timelines. SYNTAX changes that equation.

Built on proven, safe enzymatic DNA synthesis, SYNTAX gives labs the power to produce their own high-quality single-stranded DNA oligos, in-house and overnight. SYNTAX oligos perform on par with chemical DNA synthesis and leading commercial suppliers, delivering reliable, high-performance results backed by data.

Join us to discover how the SYNTAX system empowers labs performing gene synthesis to overcome uncertainty and gain a competitive advantage. By bringing DNA synthesis inside your lab, SYNTAX enables rapid iteration, empowering labs to design, produce, and test faster with full confidence in their results.

What You’ll Learn:

· How in-house oligo synthesis with the SYNTAX system streamlines gene synthesis workflows and enables rapid iteration

· How SYNTAX oligos compare to outsourced alternatives in terms of quality, consistency, and performance in downstream gene synthesis protocols.

· How dsDNA providers and shared labs that own their synthesis capability can differentiate themselves and move faster than the competition